Conference Proceedings

Ceritinib in Anaplastic Lymphoma Kinase (ALK) plus NSCLC Patients Pretreated With Only Crizotinib: ASCEND-1 Subgroup Analysis

A Shaw, D Kim, B Solomon, E Felip, G Riely, M Schuler, D Tan, L Chow, DR Camidge, P Urban, C Ortmann, I Malet, R Mehra

JOURNAL OF THORACIC ONCOLOGY | ELSEVIER SCIENCE INC | Published : 2017